- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 8 - Future of Innovation and Treatment Costs
In the concluding segment, Dr Fendrick asks the panel to provide closing remarks about the future of treating hepatitis C (HCV). Dr Afdal says he believes this is a moment in time where a revolution is taking place.
In the concluding segment, Dr Fendrick asks the panel to provide closing remarks about the future of treating hepatitis C (HCV). Dr Afdal says he believes this is a moment in time where a “revolution is taking place.” He says the industry has an opportunity—whether where treatment is done, or by whom.
“We’ve taken a disease that has significant economic, social, and health impact in the US… and made it, essentially, a disease that can be eradicated,” he says. What we really need is the ability and [the] will and economic strategy to be able to do this.”
Dr Winston says HCV can be cured, unlike HIV. He agrees that new treatments are “monumental,” and the next few years should be exciting. Dr Miller says that over 100 million people globally are afflicted with HCV. Strategies must be put into place so that the costs for treatment are shared worldwide rather than by US employers alone. Hopefully, he says, overall costs will be reduced as time progresses.
Elevating Equitable Health Care for the LGBTQ+ Community
June 18th 2024For the third episode in our special Pride Month series, we speak with Patrick McGovern, CEO of Callen-Lorde since August of 2023 and an outspoken advocate for HIV; lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+); and community health.
Listen
Community Outreach Is Enabling CeSHHAR to Close HIV Care Gaps in Zimbabwe
April 6th 2021The Centre for Sexual Health and HIV/AIDS Research Zimbabwe conducts evidence-based research related to HIV and AIDS, as well as provides and implements sexual and reproductive health education and interventions among sex workers, children, and adolescents, and in the area of masculinity.
Listen
ACC017 Showed Safety, Tolerability When Used as Antiretroviral Therapy
September 4th 2025New abstracts from the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025 found that ACC017 showed promise in its use as an antiretroviral therapy.
Read More
